CTI BioPharma Statistics
Total Valuation
Mayberry Group has a market cap or net worth of JMD 8.61 billion.
Market Cap | 8.61B |
Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, July 25, 2025.
Earnings Date | Jul 25, 2025 |
Ex-Dividend Date | May 14, 2025 |
Share Statistics
Mayberry Group has 1.20 billion shares outstanding.
Current Share Class | 1.20B |
Shares Outstanding | 1.20B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 48.67% |
Owned by Institutions (%) | n/a |
Float | 71.76M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | -4.86 |
PB Ratio | 0.39 |
P/TBV Ratio | 0.63 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 1.30.
Current Ratio | 0.94 |
Quick Ratio | 0.94 |
Debt / Equity | 1.30 |
Debt / EBITDA | n/a |
Debt / FCF | -9.79 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.77%.
Return on Equity (ROE) | -7.77% |
Return on Assets (ROA) | -2.83% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | -15.15M |
Profits Per Employee | -1.78M |
Employee Count | 117 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -519.34M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.37% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -14.37% |
50-Day Moving Average | 7.15 |
200-Day Moving Average | 7.57 |
Relative Strength Index (RSI) | 50.19 |
Average Volume (20 Days) | 8,199 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mayberry Group had revenue of JMD -1.77 billion and -208.70 million in losses. Loss per share was -0.17.
Revenue | -1.77B |
Gross Profit | -2.71B |
Operating Income | -4.57B |
Pretax Income | -2.32B |
Net Income | -208.70M |
EBITDA | n/a |
EBIT | n/a |
Loss Per Share | -0.17 |
Balance Sheet
The company has 6.14 billion in cash and 28.43 billion in debt, giving a net cash position of -22.29 billion or -18.55 per share.
Cash & Cash Equivalents | 6.14B |
Total Debt | 28.43B |
Net Cash | -22.29B |
Net Cash Per Share | -18.55 |
Equity (Book Value) | 21.94B |
Book Value Per Share | 12.59 |
Working Capital | -1.40B |
Cash Flow
In the last 12 months, operating cash flow was -2.86 billion and capital expenditures -44.69 million, giving a free cash flow of -2.90 billion.
Operating Cash Flow | -2.86B |
Capital Expenditures | -44.69M |
Free Cash Flow | -2.90B |
FCF Per Share | -2.42 |
Margins
Gross Margin | n/a |
Operating Margin | 257.98% |
Pretax Margin | 131.12% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 6.88%.
Dividend Per Share | 0.50 |
Dividend Yield | 6.88% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | 6.88% |
Earnings Yield | -2.42% |
FCF Yield | -33.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |